In cancer cells, in contrast to normal cells, the CDDP-induced DNA damage response including the activation of ATM, accumulation of γ-H2AX and p53 were not changed in the combined treatment with lovastatin (Figure 5B). The gene discussed is H2AX; the disease is cancer.